Eliquis (apixaban) has become the most prescribed blood thinner in the United States, with over 30 million prescriptions filled annually for atrial fibrillation and blood clot prevention. Its popularity stems from fewer dietary restrictions and less monitoring compared to warfarin, but that convenience doesn’t mean it’s without risk. The most important Eliquis side effects revolve around bleeding — from minor bruising to potentially life-threatening hemorrhage. Every patient on this medication needs to understand where that line falls.
How Eliquis Works as a Blood Thinner
Eliquis is a direct oral anticoagulant (DOAC) that works by selectively inhibiting Factor Xa, a key enzyme in the blood clotting cascade. By blocking Factor Xa, apixaban reduces the formation of thrombin and ultimately fibrin clots. The FDA has approved Eliquis for reducing stroke risk in non-valvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), and preventing DVT after hip or knee replacement surgery.
Unlike warfarin, Eliquis doesn’t require regular blood tests (INR monitoring) and has fewer food interactions. However, its anticoagulant effect can’t be easily measured through routine lab work, which is both an advantage and a limitation when managing side effects.
Common Eliquis Side Effects
The following Eliquis side effects are reported most frequently in clinical trials, particularly the landmark ARISTOTLE and AMPLIFY studies:
- Minor bleeding — bruising, nosebleeds, gum bleeding, and small cuts that bleed longer than usual; affects approximately 18% of patients
- Nausea — reported by about 3% of users
- Anemia — decreased hemoglobin in roughly 2-3% of patients, sometimes from occult (hidden) bleeding
- Rash — mild skin reactions in about 1-2% of users
- Elevated liver enzymes — mild, asymptomatic elevations in approximately 1% of patients
Minor bleeding events are expected consequences of any anticoagulant. Most patients learn to manage them — using a soft toothbrush, an electric razor, and being cautious with sharp objects. Nosebleeds that stop within 10-15 minutes with applied pressure are generally not concerning. However, frequent or prolonged minor bleeding should be reported to your doctor.
Serious Bleeding Risks
Major bleeding is the most significant risk with Eliquis and the side effect that carries the greatest consequences. The ARISTOTLE trial demonstrated that Eliquis causes significantly less major bleeding than warfarin — 2.13% per year versus 3.09% per year — which is a major advantage. Still, the absolute risk is not trivial.
Types of Serious Bleeding
- Gastrointestinal bleeding — stomach or intestinal bleeding occurs in about 0.76% of Eliquis patients per year; symptoms include black tarry stools, blood in vomit, or severe abdominal pain
- Intracranial hemorrhage — bleeding in the brain occurs in approximately 0.33% per year, significantly lower than warfarin’s rate; symptoms include sudden severe headache, confusion, vision changes, and weakness on one side
- Urogenital bleeding — blood in urine (hematuria) may indicate bleeding in the urinary tract
- Retroperitoneal hemorrhage — rare but serious internal bleeding
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience uncontrollable bleeding, blood in your urine or stool, vomiting blood or material that looks like coffee grounds, coughing up blood, sudden severe headache, sudden numbness or weakness, or a fall with a head injury.
The FDA approved andexanet alfa (Andexxa) as a reversal agent for Eliquis in emergency bleeding situations. Knowing that a reversal agent exists can provide some reassurance, though it is only available in hospital settings and is extremely expensive.
Drug Interactions That Increase Risk
Eliquis is metabolized primarily through the CYP3A4 enzyme and the P-glycoprotein (P-gp) transport pathway. Medications that affect these systems can significantly alter Eliquis blood levels.
- Strong CYP3A4 and P-gp inhibitors — ketoconazole, itraconazole, ritonavir, and clarithromycin increase Eliquis levels and bleeding risk; dose reduction to 2.5 mg twice daily is recommended
- Strong CYP3A4 and P-gp inducers — rifampin, carbamazepine, phenytoin, and St. John’s wort decrease Eliquis levels, potentially reducing its effectiveness and increasing clot risk; combination should be avoided
- Other anticoagulants and antiplatelets — aspirin, clopidogrel, heparin, and other blood thinners substantially increase bleeding when combined with Eliquis
- NSAIDs — ibuprofen, naproxen, and other NSAIDs increase both bleeding risk and GI ulceration risk
- SSRIs and SNRIs — antidepressants like duloxetine affect platelet function and may modestly increase bleeding risk
Always tell every healthcare provider and pharmacist that you take Eliquis. This includes dentists, urgent care doctors, and surgeons. The medication needs to be temporarily stopped before certain procedures, and the timing depends on the type of surgery and your kidney function. Visit our medical conditions guide for more on managing anticoagulant therapy.
Stopping Eliquis — Rebound Clotting Risk
Discontinuing Eliquis prematurely carries its own serious risk. The FDA includes a boxed warning on the label about increased stroke and clotting risk when the drug is stopped without adequate alternative anticoagulation. Patients with atrial fibrillation who stop Eliquis without medical guidance face a significantly higher stroke risk in the weeks following discontinuation.
If you need to stop Eliquis for surgery, your doctor will provide specific instructions on when to take the last dose and when to restart. For most procedures, stopping 24-48 hours beforehand is sufficient. Bridging with injectable heparin is rarely needed with DOACs, unlike with warfarin.
Side Effects in Specific Populations
Older Adults
Patients over 80 face higher bleeding risks. The standard dose for stroke prevention in atrial fibrillation is 5 mg twice daily, but this is reduced to 2.5 mg twice daily if two or more of the following criteria are met: age 80 or older, body weight 60 kg (132 lbs) or less, or serum creatinine 1.5 mg/dL or higher. According to the Cleveland Clinic, proper dose adjustment significantly reduces bleeding risk without sacrificing stroke protection.
Kidney Impairment
Approximately 27% of Eliquis is eliminated by the kidneys. While it’s safer in kidney disease than some other DOACs (like rivaroxaban or dabigatran), severe renal impairment still affects drug clearance. Dialysis patients present a particularly complex situation — Eliquis is sometimes used, but data is limited. Regular kidney function monitoring is important for all patients on long-term therapy.
Cancer Patients
Patients with active cancer face elevated risks of both clotting and bleeding. Eliquis is increasingly used for cancer-associated VTE based on trials like the CARAVAGGIO study, which showed comparable efficacy to low-molecular-weight heparin with acceptable bleeding rates. However, GI cancers may increase bleeding risk on Eliquis.
When to Call Your Doctor
Contact your healthcare provider if you notice:
- Frequent nosebleeds or gum bleeding that seems to be increasing
- Heavy menstrual periods or unexpected vaginal bleeding
- Pink, red, or dark brown urine
- Red or black stools
- Unusual bruising — larger or more frequent than normal
- Persistent headache or dizziness
- Joint pain and swelling (possible joint bleed)
- Any planned dental procedures or surgeries — inform providers well in advance
Frequently Asked Questions
Can I eat green vegetables while taking Eliquis?
Yes. Unlike warfarin, Eliquis is not affected by vitamin K intake, so you don’t need to restrict green leafy vegetables. You can maintain a normal, healthy diet without worrying about dietary interactions. This is one of the major practical advantages of Eliquis over warfarin.
Does Eliquis cause fatigue?
Fatigue is not a commonly reported side effect in clinical trials. However, if Eliquis is causing undetected slow bleeding (occult blood loss), the resulting anemia could manifest as fatigue and weakness. If you feel unusually tired on Eliquis, your doctor may check your hemoglobin and iron levels.
What happens if I miss a dose of Eliquis?
Take the missed dose as soon as you remember on the same day, then resume your regular schedule. Do not double the dose. If you don’t remember until the next scheduled dose, skip the missed one entirely. Consistent twice-daily dosing is important because Eliquis has a relatively short half-life of about 12 hours.
Is Eliquis safer than warfarin?
For most patients with non-valvular atrial fibrillation, clinical trials show Eliquis causes fewer major bleeding events and fewer strokes than warfarin. It also has a lower rate of intracranial hemorrhage. However, warfarin remains the preferred anticoagulant for patients with mechanical heart valves or certain other conditions. Your doctor can determine which option is best for your situation.
Practical Takeaways on Eliquis Side Effects
Living safely on Eliquis means understanding that some bleeding is expected and learning to distinguish everyday minor bleeding from warning signs of serious hemorrhage. Eliquis side effects are dominated by bleeding events, but the drug’s clinical profile is substantially better than warfarin for most patients. Avoid NSAIDs, report any new medications to your doctor, and never stop Eliquis without medical guidance. Carry identification indicating you take an anticoagulant, and make sure every healthcare provider you see knows about your medication.